Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -2.45% | 98.56 | 0.0% | $1438.14m | |
| BIIB | Biogen, Inc. | -0.36% | 242.51 | 1.7% | $630.38m | |
| AMGN | Amgen, Inc. | -0.79% | 220.46 | 1.3% | $568.17m | |
| GILD | Gilead Sciences, Inc. | 0.60% | 60.25 | 1.0% | $535.76m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.63% | 216.50 | 1.9% | $470.81m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -3.34% | 506.10 | 2.7% | $447.76m | |
| BNTX | BioNTech SE | -4.35% | 101.87 | 0.0% | $424.45m | |
| ILMN | Illumina, Inc. | 1.25% | 305.63 | 3.5% | $377.98m | |
| NVAX | Novavax, Inc. | 1.44% | 95.33 | 92.9% | $339.05m | |
| EXAS | EXACT Sciences Corp. | -2.72% | 117.26 | 19.6% | $289.27m | |
| MGEN | Miragen Therapeutics, Inc. | -4.62% | 16.50 | 0.7% | $248.55m | |
| SRRK | Scholar Rock Holding Corp. | 3.14% | 42.70 | 0.0% | $242.63m | |
| APVO | Aptevo Therapeutics, Inc. | -3.58% | 43.92 | 18.3% | $210.20m | |
| SGEN | Seagen Inc. | -2.05% | 164.63 | 5.8% | $167.34m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.41% | 123.11 | 2.0% | $161.56m |
Company Profile
Otonomy, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for neurotology. The firm's product pipeline includes OTIVIDEX (dexamethasone) Ménière's disease; OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT); OTO-313 (gacyclidine) tinnitus; OTO-413 (BDNF) hidden hearing Loss; OTO-510 (otoprotectant) prevent CIHL; OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan in April 2008 and is headquartered in San Diego, CA.